Clinical Research Directory
Browse clinical research sites, groups, and studies.
Autoimmune Blistering Diseases Study
Sponsor: University of Pennsylvania
Summary
Pemphigus and bullous pemphigoid (BP) are severe autoimmune blistering diseases (AIBD) that pose a critical need for new therapeutic approaches. Clinical trials in pemphigus and BP will require the availability of validated disease severity measures that can be used to define primary outcomes.
Official title: Prevalence and Clinical Severity of Autoimmune Blistering Diseases
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
150
Start Date
2016-04
Completion Date
2030-01-02
Last Updated
2026-03-30
Healthy Volunteers
No
Interventions
Questionnaires
Locations (3)
Hospital of the University of Pennsylvania, Department of Dermatology
Philadelphia, Pennsylvania, United States
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
University of Pennsylvania, Department of Dermatology
Philadelphia, Pennsylvania, United States